Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study - Wikidata - awgldk - TriplyDB

Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study

Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study

http://www.wikidata.org/entity/Q30781344

about

Adoptive T-cell therapy for fungal infections in haematology patients Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue.Invasive Aspergillus Sinusitis in Human Immunodeficiency Virus Infection: Case Report and Review of the Literature The CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis.Severe Pneumocystis jirovecii pneumonia in an idiopathic CD4+ lymphocytopenia patient: case report and review of the literature.Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs Virulence of Candida albicans isolated from HIV infected and non infected individuals.Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection.Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.Characterisation of an ABC transporter of a resistant Candida glabrata clinical isolate.

P2860

Q26781064-41F29D70-965F-4D2B-9239-6768A57229AC Q27323146-42DC5B1B-8327-4F23-B376-AAD98055F5DE Q28078679-0BDDF950-2FD8-4075-B9A8-3CEDE0F4016F Q33575765-E1C9CABA-C8AF-41B2-8BC8-F1AAF872A78A Q33635195-AC3E8E1B-9E83-499E-8C7B-FC1670C5950D Q35515892-58DA6261-AB63-4F37-A48E-5470EB14654F Q35743458-B007E4E5-F7E9-441A-9054-5AB7B379F1BB Q36610943-1DC4DB59-BBC4-426F-94FB-9CB8AD27F03F Q37631771-7CAD04DB-9255-4ABE-B777-04443D0C521A Q50142221-F56AD843-08F3-4B4A-AC21-182650BF0FF2

P2860

Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study

http://www.wikidata.org/entity/Q30781344

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical characteristics and o ...... lticenter, observational study

@ast

Clinical characteristics and o ...... lticenter, observational study

@en

type

label

Clinical characteristics and o ...... lticenter, observational study

@ast

Clinical characteristics and o ...... lticenter, observational study

@en

prefLabel

Clinical characteristics and o ...... lticenter, observational study

@ast

Clinical characteristics and o ...... lticenter, observational study

@en

P1433

Q30781344-B1B75C29-4752-458D-B047-92014CB977A8

P1476

Q30781344-30AA04D6-2B7C-4CF1-93F4-411BAD478575

P2093

Q30781344-168BF37C-BE78-4514-A920-0493756A4DAD

Q30781344-1ED2974D-2BED-411E-9177-67B2D94C6128

Q30781344-3A370BCF-908C-47C3-A88C-8B0DF2DFFDC2

Q30781344-79408A81-2877-43CF-95D5-A80681D58BD2

Q30781344-E8CCDF26-C48A-4B5A-9CDD-2ED5661FDA63

P2860

Q30781344-04478CD1-2952-4A66-9D29-4A1DA4011ABD

Q30781344-0B07CE85-5335-43A1-B9A2-33A7F329A012

Q30781344-1C06A8D2-D4AB-4E07-BF6F-9AB2E8961A18

Q30781344-2431AFDD-30DC-456A-8C56-1F919103F48B

Q30781344-26963CC6-A54C-4B4E-B34E-7AC147FF6D53

Q30781344-2A0A7769-AFF7-41C1-9092-2EB9D43DBB0B

Q30781344-2C949CB0-1470-4BA8-874D-ECA4B75921C6

Q30781344-2D76746F-01E7-4834-B73A-64A6529AEF4B

Q30781344-3746D490-4764-4958-9178-B23A34AAC2A4

Q30781344-3D105B38-5974-478C-A2D5-B3B25E30642F

P304

Q30781344-E17DE826-675C-475A-8C9D-B2ABB8A2293E

P31

Q30781344-BB75488B-168A-4F16-9CD4-7EC09EE802AC

P356

Q30781344-7465437A-D0FE-4D82-BE25-CF2BF491733A

P407

Q30781344-FD7C9B64-89CF-4798-B0E1-1FAE8BEAD1F0

P478

Q30781344-A93915AE-4055-4B79-A293-D5D9C5017B93

P50

Q30781344-02892788-818A-41DD-A64F-33A9AE4054AC

P577

Q30781344-0F5C363A-9E9A-4DD6-B1C4-6FFB164E893D

P698

Q30781344-D7519962-7FB3-40CB-947E-19CDEFAAB70D

P921

Q30781344-4E918F3E-2894-44A1-9A49-361A34CC49E5

P932

Q30781344-DCA69C60-ABF0-4AF8-93B3-F37717D7D465

P356

P1433

HIV/AIDS – Research and Palliative Care

P1476

Clinical characteristics and o ...... lticenter, observational study

@en

P2093

David L Horn

http://www.w3.org/2001/XMLSchema#string

Herwig-Ulf Meier-Kriesche

http://www.w3.org/2001/XMLSchema#string

Nkechi Azie

http://www.w3.org/2001/XMLSchema#string

Shirish Huprikar

http://www.w3.org/2001/XMLSchema#string

Shun-Ping Quan

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

HIV-associated opportunistic pneumonias

HIV: primary and secondary prophylaxis for opportunistic infections.

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

P304

39-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/HIV.S53910

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Tafireyi Marukutira

P577

2014-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24648769

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

3958502

http://www.w3.org/2001/XMLSchema#string